These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26400567)

  • 1. Podocyte Expression of B7-1/CD80: Is it a Reliable Biomarker for the Treatment of Proteinuric Kidney Diseases with Abatacept?
    Salant DJ
    J Am Soc Nephrol; 2016 Apr; 27(4):963-5. PubMed ID: 26400567
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of T-cell activation by the CTLA4-Fc Abatacept is sufficient to ameliorate proteinuric kidney disease.
    Herrera M; Söderberg M; Sabirsh A; Valastro B; Mölne J; Santamaria B; Valverde AM; Guionaud S; Heasman S; Bigley A; Jermutus L; Rondinone C; Coghlan M; Baker D; Quinn CM
    Am J Physiol Renal Physiol; 2017 Apr; 312(4):F748-F759. PubMed ID: 27440778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of B7-1 in proteinuria of glomerular origin.
    Novelli R; Benigni A; Remuzzi G
    Nat Rev Nephrol; 2018 Sep; 14(9):589-596. PubMed ID: 29959373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abatacept in B7-1-positive proteinuric kidney disease.
    Yu CC; Fornoni A; Weins A; Hakroush S; Maiguel D; Sageshima J; Chen L; Ciancio G; Faridi MH; Behr D; Campbell KN; Chang JM; Chen HC; Oh J; Faul C; Arnaout MA; Fiorina P; Gupta V; Greka A; Burke GW; Mundel P
    N Engl J Med; 2013 Dec; 369(25):2416-23. PubMed ID: 24206430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTLA4-Ig in B7-1-positive diabetic and non-diabetic kidney disease.
    Bassi R; Fornoni A; Doria A; Fiorina P
    Diabetologia; 2016 Jan; 59(1):21-29. PubMed ID: 26409459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B7-1 Is Not Induced in Podocytes of Human and Experimental Diabetic Nephropathy.
    Gagliardini E; Novelli R; Corna D; Zoja C; Ruggiero B; Benigni A; Remuzzi G
    J Am Soc Nephrol; 2016 Apr; 27(4):999-1005. PubMed ID: 26319246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The costimulatory receptor B7-1 is not induced in injured podocytes.
    Baye E; Gallazzini M; Delville M; Legendre C; Terzi F; Canaud G
    Kidney Int; 2016 Nov; 90(5):1037-1044. PubMed ID: 27528551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podocyte-Targeted Treatment for Proteinuric Kidney Disease.
    Mundel P
    Semin Nephrol; 2016 Nov; 36(6):459-462. PubMed ID: 27987545
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of podocyte B7-1 in diabetic nephropathy.
    Fiorina P; Vergani A; Bassi R; Niewczas MA; Altintas MM; Pezzolesi MG; D'Addio F; Chin M; Tezza S; Ben Nasr M; Mattinzoli D; Ikehata M; Corradi D; Schumacher V; Buvall L; Yu CC; Chang JM; La Rosa S; Finzi G; Solini A; Vincenti F; Rastaldi MP; Reiser J; Krolewski AS; Mundel PH; Sayegh MH
    J Am Soc Nephrol; 2014 Jul; 25(7):1415-29. PubMed ID: 24676639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?
    Novelli R; Gagliardini E; Ruggiero B; Benigni A; Remuzzi G
    Am J Physiol Renal Physiol; 2016 Mar; 310(5):F335-41. PubMed ID: 26697986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing therapeutic 'arrows' with the precision of William Tell: the time has come for targeted therapies in kidney disease.
    Mundel P; Greka A
    Curr Opin Nephrol Hypertens; 2015 Jul; 24(4):388-92. PubMed ID: 26050127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abatacept Treatment Does Not Preserve Renal Function in the Streptozocin-Induced Model of Diabetic Nephropathy.
    Norlin J; Nielsen Fink L; Helding Kvist P; Douglas Galsgaard E; Coppieters K
    PLoS One; 2016; 11(4):e0152315. PubMed ID: 27055155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocytes: the Weakest Link in Diabetic Kidney Disease?
    Lin JS; Susztak K
    Curr Diab Rep; 2016 May; 16(5):45. PubMed ID: 27053072
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Chen W; Wu Y; Zhang G; Wang M; Yang H; Li Q
    Biomed Res Int; 2018; 2018():5647120. PubMed ID: 29862277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of CD80 on glomerular podocytes plays an important role in development of proteinuria following pig-to-baboon xeno-renal transplantation - an experimental study.
    Rivard CJ; Tanabe T; Lanaspa MA; Watanabe H; Nomura S; Andres-Hernando A; Garth K; Sekijima M; Ishimoto T; Ariyoshi Y; Garcia GE; Shah J; Lennan B; Tasaki M; Pomposelli T; Shimizu A; Sachs DH; Johnson RJ; Yamada K
    Transpl Int; 2018 Oct; 31(10):1164-1177. PubMed ID: 29722117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podocyte hypertrophy in diabetic nephropathy.
    Kim NH
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S14-6. PubMed ID: 16174280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new era of podocyte-targeted therapy for proteinuric kidney disease.
    Haraldsson B
    N Engl J Med; 2013 Dec; 369(25):2453-4. PubMed ID: 24206429
    [No Abstract]   [Full Text] [Related]  

  • 18. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
    Ilatovskaya DV; Staruschenko A
    Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of podocyte autophagy in the progression of diabetic nephropathy.
    Yasuda-Yamahara M; Kume S; Tagawa A; Maegawa H; Uzu T
    Autophagy; 2015; 11(12):2385-6. PubMed ID: 26565953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt signaling and podocyte dysfunction in diabetic nephropathy.
    Bose M; Almas S; Prabhakar S
    J Investig Med; 2017 Dec; 65(8):1093-1101. PubMed ID: 28935636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.